Paracetamol phenylephrine hydrochloride and cetirizine dihydrochloride suspension

If you are taking the over-the-counter product to self-treat, read all directions on the product package before taking this If you are using the chewable tablets, chew each tablet well and swallow. If you are using the rapidly-dissolving tablet, allow the tablet to dissolve on the The dosage is based on your age, medical condition, and response to treatment. Do not increase your dose or take this medication more often than directed. Tell your doctor if your Drowsiness, tiredness, and If your doctor has prescribed this Tell your doctor right away if you have any serious side effects, including: difficulty urinating, A very serious This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345. Before taking Before using this If you are using this medication to This drug may make you drowsy. Alcohol or Liquid products may contain sugar. Caution is advised if you have Before having surgery, tell your doctor or During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor. This medication passes into Store at room temperature away from light and moisture. Do not store in ...

Development and validation of a novel RP-HPLC method for simultaneous determination of paracetamol, phenylephrine hydrochloride, caffeine, cetirizine and nimesulide in tablet formulation - ScienceDirect JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. Skip to main content Skip to article The present work describes development and validation of a high-performance liquid chromatography–diode array detection (HPLC–DAD) procedure for the analysis of phenylephrine hydrochloride (PHE), paracetamol (PAR), caffeine anhydrous (CAF), cetirizine Dihydrochloride (CET), nimesulide (NIM) in pharmaceutical mixture. Effective chromatographic separation of PHE, PAR, CAF, CET and NIM was achieved using a Kinetex-C18 (4.6mm, 150mm, 5mm) column with gradient elution of the mobile phase composed of 10mM phosphate buffer (pH 3.3) and acetonitrile. The elution was a three step gradient elution program step-1 started initially with 2% (by volume) acetonitrile and 98% phosphate buffer (pH 3.3) for first 2min. In step-2 acetonitrile concentration changed linearly to 20% up to 12min the analysis was concluded by step-3 changing acetonitrile to 2% up to 20min. The proposed HPLC method was statistically validated with respect to linearity, ranges, precision, accuracy, selectivity and robustness. Calibration curves were linear in the ranges of 5–100, 100–1000 and 10–200mg/mL for PHE, PAR, CAF, CET and NIM respectively, with correlation coefficients ...

Chlorpheniramine and phenylephrine Generic name: chlorpheniramine and phenylephrine [ KLOR-fen-IR-a-meen-and-FEN-il-EFF-rin] Brand names: Actifed Cold & Allergy, Cold & Allergy Relief, Dallergy Drops, Ed A-Hist, Ed ChlorPed D, NoHist LQ, Phenagil, R-Tanna, Sinus & Allergy PE, Sudafed PE Sinus & Allergy, Phenylhistine, Novahistine Elixir, Histatab Plus, Ed A-Hist LA, Rynatan Pediatric, Rynatan, Phenchlor Tannate Pediatric, Relera, Rondec Drops, Rondec, Ceron, Ceron Drops, Chlor-Mes Jr, Dallergy-JR, Rondex, Rondex Drops, Ny-Tannic, Dec-Chlorphen, Dec-Chlorphen Drops, C Phen Drops, C Phen, Tannate Pediatric, Histadec, PediaTan D, Sudafed PE Sinus and Allergy, Rescon-Jr, CP Dec, Cardec Drops, P-Tann D, Triaminic Cold/Allergy, Rinate Pediatric, Cardec, AlleRx, Sildec-PE Drops, Sildec-PE, Nasohist Pediatric, Sinus and Allergy PE, PD-Hist D Drops, PD-Hist D, CP Dec Drops, Tanahist-D, Ry-Tann, Sonahist, Cold and Allergy Relief, Sinus and Allergy Maximum Strength, Actifed Cold and Allergy, NoHist, Trigofen Drops, Lohist, Virdec, Maxichlor PEH, Giltuss Allergy and Sinus Dosage forms: oral liquid (1 mg-2.5 mg/5 mL; 1 mg-2.5 mg/mL; 2 mg-5 mg/mL; 4 mg-10 mg/5 mL), oral suspension (4.5 mg-5 mg/5 mL), oral suspension, extended release (4 mg-20 mg/5 mL; 8 mg-10 mg/5 mL), oral tablet (3.5 mg-10 mg; 4 mg-10 mg) Drug class: • • • • • • Before taking this medicine You should not use this medicine if you are allergic to chlorpheniramine or phenylephrine. Do not use this medicine if you have us...

Background Common cold is a frequent illness in northern hemisphere between late autumn and early spring. Patients suffering from it frequently turn to pharmacists instead of physicians in order to receive medical advice and treatment. We studied its treatment advised by pharmacists in Poland, as well as evidence for the efficacy of their recommendations by utilizing a self-developed questionnaire and a study of existing literature. Methods The data were collected by 27 pharmacists who worked in four large network community pharmacies in Lodz, Poland. The study took place from December 2019 to February 2020. Data were recorded only if the patient asked for pharmacy counselling for over-the counter (OTC) products due to common cold self-diagnosis and a product was sold. Pharmacists’ recommendations were compared with the results of a literature review of best evidence to determine appropriateness of the pharmacists’ decisions. Results In four out of five cases the pharmacists recommended products contained paracetamol. In addition, in one out of three patient encounters they advised nasal decongestant, inosines and/or OTC mucolytics. There was a significant relationship between fever and recommendation frequency of some analgesics, inosines, mucolytics and sore throat products (OR > 1, p  1, p  1, p  1, p < 0.05). The pharmacist recommendations were based on patients’ symptoms, product price, pharmaceutical company promotion and the financial incen...

Aceclofenac + Paracetamol + Cetirizine + Phenylephrine + Caffeine is a combination of five medicines : Aceclofenac, Paracetamol, Cetirizine, Phenylephrine, and Caffeine, that helps treat common cold symptoms. Aceclofenac is a non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling). Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer). It works by blocking the release of certain chemical messengers that cause pain and fever. Cetirizine is an antihistamine medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body. Phenylephrine is a decongestant which narrows the small blood vessels providing relief from congestion or stuffiness in the nose. Caffeine is a stimulant which decreases sleepiness caused by Cetirizine.

What is this medication? ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE (a set a MEE noe fen; gwye FEN e sin; fen il EF rin) is a combination of a pain reliever, expectorant and decongestant. It is used to treat fever, aches and pains, and congestion from a cold or the flu. It is also used to treat a dry cough. This medicine will not treat an infection. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. COMMON BRAND NAME(S): Duratuss A, Mucinex Fast-Max, Mucinex Fast-Max Congestion & Headache, Mucinex Sinus-Max, Sudafed PE Head Congestion + Mucus, Sudafed PE Pressure + Pain + Mucus, Sudafed PE Triple Action, Tylenol Cold Head Congestion Severe, Tylenol Sinus, Tylenol Sinus Congestions & Pain Severe Daytime, Tylenol Sinus Severe Congestion What should I tell my care team before I take this medication? They need to know if you have any of these conditions: • diabetes • glaucoma • heart disease • high blood pressure • if you often drink alcohol • peripheral vascular disease • prostate disease • taken a MAOI like Carbex, Eldepryl, Marplan, Nardil, or Parnate within the last 14 days • thyroid disease • an unusual or allergic reaction to acetaminophen, guaifenesin, phenylephrine, other medicines, foods, dyes, or preservatives • pregnant or trying to get pregnant • breast-feeding How should I use this medication? Take this medicine by mouth with a full glass of water. Follow the directions on the label. Take your medicine a...

Chlorpheniramine and phenylephrine Generic name: chlorpheniramine and phenylephrine [ KLOR-fen-IR-a-meen-and-FEN-il-EFF-rin] Brand names: Actifed Cold & Allergy, Cold & Allergy Relief, Dallergy Drops, Ed A-Hist, Ed ChlorPed D, NoHist LQ, Phenagil, R-Tanna, Sinus & Allergy PE, Sudafed PE Sinus & Allergy, Phenylhistine, Novahistine Elixir, Histatab Plus, Ed A-Hist LA, Rynatan Pediatric, Rynatan, Phenchlor Tannate Pediatric, Relera, Rondec Drops, Rondec, Ceron, Ceron Drops, Chlor-Mes Jr, Dallergy-JR, Rondex, Rondex Drops, Ny-Tannic, Dec-Chlorphen, Dec-Chlorphen Drops, C Phen Drops, C Phen, Tannate Pediatric, Histadec, PediaTan D, Sudafed PE Sinus and Allergy, Rescon-Jr, CP Dec, Cardec Drops, P-Tann D, Triaminic Cold/Allergy, Rinate Pediatric, Cardec, AlleRx, Sildec-PE Drops, Sildec-PE, Nasohist Pediatric, Sinus and Allergy PE, PD-Hist D Drops, PD-Hist D, CP Dec Drops, Tanahist-D, Ry-Tann, Sonahist, Cold and Allergy Relief, Sinus and Allergy Maximum Strength, Actifed Cold and Allergy, NoHist, Trigofen Drops, Lohist, Virdec, Maxichlor PEH, Giltuss Allergy and Sinus Dosage forms: oral liquid (1 mg-2.5 mg/5 mL; 1 mg-2.5 mg/mL; 2 mg-5 mg/mL; 4 mg-10 mg/5 mL), oral suspension (4.5 mg-5 mg/5 mL), oral suspension, extended release (4 mg-20 mg/5 mL; 8 mg-10 mg/5 mL), oral tablet (3.5 mg-10 mg; 4 mg-10 mg) Drug class: • • • • • • Before taking this medicine You should not use this medicine if you are allergic to chlorpheniramine or phenylephrine. Do not use this medicine if you have us...

If you are taking the over-the-counter product to self-treat, read all directions on the product package before taking this If you are using the chewable tablets, chew each tablet well and swallow. If you are using the rapidly-dissolving tablet, allow the tablet to dissolve on the The dosage is based on your age, medical condition, and response to treatment. Do not increase your dose or take this medication more often than directed. Tell your doctor if your Drowsiness, tiredness, and If your doctor has prescribed this Tell your doctor right away if you have any serious side effects, including: difficulty urinating, A very serious This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345. Before taking Before using this If you are using this medication to This drug may make you drowsy. Alcohol or Liquid products may contain sugar. Caution is advised if you have Before having surgery, tell your doctor or During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor. This medication passes into Store at room temperature away from light and moisture. Do not store in ...

Development and validation of a novel RP-HPLC method for simultaneous determination of paracetamol, phenylephrine hydrochloride, caffeine, cetirizine and nimesulide in tablet formulation - ScienceDirect JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. Skip to main content Skip to article The present work describes development and validation of a high-performance liquid chromatography–diode array detection (HPLC–DAD) procedure for the analysis of phenylephrine hydrochloride (PHE), paracetamol (PAR), caffeine anhydrous (CAF), cetirizine Dihydrochloride (CET), nimesulide (NIM) in pharmaceutical mixture. Effective chromatographic separation of PHE, PAR, CAF, CET and NIM was achieved using a Kinetex-C18 (4.6mm, 150mm, 5mm) column with gradient elution of the mobile phase composed of 10mM phosphate buffer (pH 3.3) and acetonitrile. The elution was a three step gradient elution program step-1 started initially with 2% (by volume) acetonitrile and 98% phosphate buffer (pH 3.3) for first 2min. In step-2 acetonitrile concentration changed linearly to 20% up to 12min the analysis was concluded by step-3 changing acetonitrile to 2% up to 20min. The proposed HPLC method was statistically validated with respect to linearity, ranges, precision, accuracy, selectivity and robustness. Calibration curves were linear in the ranges of 5–100, 100–1000 and 10–200mg/mL for PHE, PAR, CAF, CET and NIM respectively, with correlation coefficients ...

Background Common cold is a frequent illness in northern hemisphere between late autumn and early spring. Patients suffering from it frequently turn to pharmacists instead of physicians in order to receive medical advice and treatment. We studied its treatment advised by pharmacists in Poland, as well as evidence for the efficacy of their recommendations by utilizing a self-developed questionnaire and a study of existing literature. Methods The data were collected by 27 pharmacists who worked in four large network community pharmacies in Lodz, Poland. The study took place from December 2019 to February 2020. Data were recorded only if the patient asked for pharmacy counselling for over-the counter (OTC) products due to common cold self-diagnosis and a product was sold. Pharmacists’ recommendations were compared with the results of a literature review of best evidence to determine appropriateness of the pharmacists’ decisions. Results In four out of five cases the pharmacists recommended products contained paracetamol. In addition, in one out of three patient encounters they advised nasal decongestant, inosines and/or OTC mucolytics. There was a significant relationship between fever and recommendation frequency of some analgesics, inosines, mucolytics and sore throat products (OR > 1, p  1, p  1, p  1, p < 0.05). The pharmacist recommendations were based on patients’ symptoms, product price, pharmaceutical company promotion and the financial incen...